EUVIMEDEUVIMED entdecken
Crossref

PTGR1-mediated immune evasion mechanisms in late-stage triple-negative breast cancer: mechanisms of M2 macrophage infiltration and CD8+ T cell suppression

Fang Huang, Fuhe Wang, Qilu Hu, Ying Li, Da Jiang

Apoptosis · 2024

DOI: 10.1007/s10495-024-01991-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Apoptosis, 2024. Verfasst von Fang Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, East Campus, No.169 Tianshan Street, Shijiazhuang, 050000, Hebei Pro…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, CD8-Positive T-Lymphocytes, Macrophages, Tumor Microenvironment. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Hebei Provincial Medical Science Research Project Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is a heterogeneous disease characterized by metabolic dysregulation. Tumor cell immune escape plays an indispensable role in the development of TNBC tumors. Furthermore, in the abstract, we explicitly mention the techniques used and enhance the clarity and impact of our findings. "Based on bioinformatics analysis results, we utilized CRISPR/Cas9 technology to knockout the target gene and established a mouse model of breast cancer. Through experiments such as CCK8, scratch assay, and Transwell assay, we further investigated the impact of target gene knockout on the malignant behavior of tumor cells. Subsequently, we conducted immunohistochemistry and Western Blot experiments to study the expression of macrophage polarization and infiltration-related markers and evaluate the effect of the target gene on macrophage polarization. Next, through co-culture experiments, we simulated the tumor microenvironment and used immunohistochemistry staining to observe and analyze the distribution and activation status of M2 macrophages and CD8+ T cells in the co-culture system. We validated in vivo experiments the molecular mechanism by which the target gene regulates immune cell impact on TNBC progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsCD8-Positive T-LymphocytesMacrophagesTumor MicroenvironmentAnimalsMiceFemaleHumansCell Line, TumorTumor EscapeCoculture TechniquesTumor-Associated Macrophages

Stichwörter der Autor:innen

CD8+ T cellsImmune evasionM2 macrophagesPD-L1PTGR1Triple-negative breast cancer

Autor:innen und Institutionen

  • Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, East Campus, No.169 Tianshan Street, Shijiazhuang, 050000, Hebei Province, P. R. China.
  • Department of General surgery, Hebei Yiling Hospital, Shijiazhuang, 050000, P. R. China.
  • Department of Radiotherapy, Heze Traditional Chinese Medicine Hospital, Heze, 274008, P. R. China.
  • Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, East Campus, No.169 Tianshan Street, Shijiazhuang, 050000, Hebei Province, P. R. China. jiangda139@163.com.

Förderung

  • Hebei Provincial Medical Science Research Project Program

Zitieren

APA

Huang, F., Wang, F., Hu, Q., Li, Y., & Jiang, D. (2024). PTGR1-mediated immune evasion mechanisms in late-stage triple-negative breast cancer: mechanisms of M2 macrophage infiltration and CD8+ T cell suppression. Apoptosis. https://doi.org/10.1007/s10495-024-01991-0

Vancouver

Huang F, Wang F, Hu Q, Li Y, Jiang D. PTGR1-mediated immune evasion mechanisms in late-stage triple-negative breast cancer: mechanisms of M2 macrophage infiltration and CD8+ T cell suppression. Apoptosis. 2024. doi:10.1007/s10495-024-01991-0

BibTeX
@article{Huang2024,
  author = {Huang, Fang and Wang, Fuhe and Hu, Qilu and Li, Ying and Jiang, Da},
  title = {PTGR1-mediated immune evasion mechanisms in late-stage triple-negative breast cancer: mechanisms of M2 macrophage infiltration and CD8+ T cell suppression},
  journal = {Apoptosis},
  year = {2024},
  doi = {10.1007/s10495-024-01991-0}
}
Kostenlos starten →